1. Home
  2. AERT vs SGMT Comparison

AERT vs SGMT Comparison

Compare AERT & SGMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AERT
  • SGMT
  • Stock Information
  • Founded
  • AERT 2012
  • SGMT 2006
  • Country
  • AERT Singapore
  • SGMT United States
  • Employees
  • AERT N/A
  • SGMT N/A
  • Industry
  • AERT Professional Services
  • SGMT
  • Sector
  • AERT Consumer Discretionary
  • SGMT
  • Exchange
  • AERT Nasdaq
  • SGMT Nasdaq
  • Market Cap
  • AERT 99.7M
  • SGMT 93.7M
  • IPO Year
  • AERT N/A
  • SGMT 2023
  • Fundamental
  • Price
  • AERT $1.06
  • SGMT $4.73
  • Analyst Decision
  • AERT
  • SGMT Strong Buy
  • Analyst Count
  • AERT 0
  • SGMT 5
  • Target Price
  • AERT N/A
  • SGMT $21.60
  • AVG Volume (30 Days)
  • AERT 55.3K
  • SGMT 792.4K
  • Earning Date
  • AERT 11-26-2024
  • SGMT 11-13-2024
  • Dividend Yield
  • AERT N/A
  • SGMT N/A
  • EPS Growth
  • AERT N/A
  • SGMT N/A
  • EPS
  • AERT N/A
  • SGMT N/A
  • Revenue
  • AERT $72,846,000.00
  • SGMT N/A
  • Revenue This Year
  • AERT N/A
  • SGMT N/A
  • Revenue Next Year
  • AERT N/A
  • SGMT N/A
  • P/E Ratio
  • AERT N/A
  • SGMT N/A
  • Revenue Growth
  • AERT 28.04
  • SGMT N/A
  • 52 Week Low
  • AERT $1.00
  • SGMT $2.31
  • 52 Week High
  • AERT $3.12
  • SGMT $20.71
  • Technical
  • Relative Strength Index (RSI)
  • AERT 19.59
  • SGMT 41.81
  • Support Level
  • AERT $1.18
  • SGMT $5.61
  • Resistance Level
  • AERT $1.75
  • SGMT $6.40
  • Average True Range (ATR)
  • AERT 0.20
  • SGMT 0.53
  • MACD
  • AERT -0.04
  • SGMT -0.16
  • Stochastic Oscillator
  • AERT 6.49
  • SGMT 8.24

About AERT Aeries Technology Inc.

Aeries Technology Inc is a professional and management services partner offering a range of management consultancy services for private equity sponsors and their portfolio companies with engagement models that are designed to provide a mix of deep vertical specialty, functional expertise, and digital systems and solutions to scale, optimize and transform a client's business operations. It supports and drives its client's growth across the globe by providing a range of management consultancy services involving professional advisory services and operations management services to build and manage dedicated delivery centers in appropriate locations based on customer business needs.

About SGMT Sagimet Biosciences Inc. Series A

Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company focused on developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional lipid metabolism pathways. The company's lead drug candidate, denifanstat, is an oral, once-daily pill and selective FASN inhibitor in development for the treatment of nonalcoholic steatohepatitis (NASH).

Share on Social Networks: